Patents Assigned to ONCODIAG
  • Methods for the surveillance, diagnosis and screening of bladder cancer
    Patent number: 11060152
    Abstract: A method of diagnosing or predicting a bladder cancer, or a risk of a developing a bladder cancer in a subject is provided, which method includes the detection of specific mutations in the FGFR3 gene in a first biological sample; and the measure of the degree of methylation of target genes in a biological sample obtained from the subject in a second biological sample.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: July 13, 2021
    Assignee: ONCODIAG
    Inventor: Jean-Pierre Roperch